文献速递美容整形

氨甲环酸与地塞米松对鼻整形术后水肿和瘀斑的头对头比较

Topical Tranexamic Acid and Systemic Dexamethasone for Post-rhinoplasty Edema and Ecchymosis: First Direct Comparison.
PubMed 文献 · Aesthet Surg J · 2025-01-01

一项前瞻性、随机、三盲对照试验纳入60例鼻整形患者,随机分为局部氨甲环酸组、全身地塞米松组、联合治疗组和对照组(各15例)。局部氨甲环酸与全身地塞米松均较对照组显著减轻术后水肿和瘀斑(P < .05),两者间无显著差异,联合治疗未提供额外获益。

要点

  • 局部氨甲环酸与全身地塞米松均较对照组显著减轻鼻整形术后水肿和瘀斑(P < .05)。
  • 局部氨甲环酸与全身地塞米松之间疗效无显著差异。
  • 联合治疗较单药治疗未提供额外获益。

核心结论

  • 局部氨甲环酸在减轻鼻整形术后水肿和瘀斑方面与全身地塞米松同样有效,可作为可行替代方案,尤其适用于有皮质激素禁忌证的患者。
  • 两药联合未产生额外获益。

研究设计与样本

  • 前瞻性、随机、三盲对照试验,纳入60例患者,随机分为局部氨甲环酸组(n = 15)、全身地塞米松组(n = 15)、联合治疗组(n = 15)和对照组(n = 15)。
  • 采用标准化临床评分在术后第1、3、7天评估眶周水肿和瘀斑,组间和组内比较使用适当统计检验,显著性阈值P ≤ .05。

主要发现

  • 局部氨甲环酸和全身地塞米松均较对照组显著减轻术后水肿和瘀斑(P < .05)。
  • 局部氨甲环酸与全身地塞米松之间无显著差异。
  • 联合治疗较单药治疗未提供额外获益。

临床怎么用

  • 局部氨甲环酸可作为全身地塞米松的可行替代方案,尤其适用于有皮质激素禁忌证的患者。
  • 联合使用局部氨甲环酸与全身地塞米松未显示额外获益。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative edema and ecchymosis are common concerns following rhinoplasty, often prolonging recovery and affecting patient satisfaction. Systemic dexamethasone is widely used to reduce these complications, and topical tranexamic acid has recently gained attention. However, no study has directly compared their efficacy or evaluated their combined effect. OBJECTIVES: This study aimed to compare the effectiveness of topical tranexamic acid, systemic dexamethasone, and their combination in reducing postoperative edema and ecchymosis after rhinoplasty. METHODS: A prospective, randomized, triple-blind controlled trial was conducted on 60 patients, who were randomly assigned into 4 groups: topical tranexamic acid (n = 15), systemic dexamethasone (n = 15), combination therapy (n = 15), and control (n = 15). Standardized clinical scoring was used to assess periorbital edema and ecchymosis on postoperative days 1, 3, and 7. Intergroup and intragroup comparisons were performed using appropriate statistical tests, with a significance threshold of P ≤ .05. RESULTS: Both topical tranexamic acid and systemic dexamethasone significantly reduced postoperative edema and ecchymosis compared with the control group (P < .05), with no significant difference between them. The combination therapy provided no additional benefit over monotherapy. CONCLUSIONS: Topical tranexamic acid is as effective as systemic dexamethasone in reducing postoperative edema and ecchymosis, making it a viable alternative, especially for patients with contraindications to corticosteroids. The combination of both agents did not yield additional benefits.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Vural O, Koycu A. Topical Tranexamic Acid and Systemic Dexamethasone for Post-rhinoplasty Edema and Ecchymosis: First Direct Comparison. Aesthet Surg J. 2025. PMID: 40343983. doi:10.1093/asj/sjaf073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。